Actively Recruiting
Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
Led by M.D. Anderson Cancer Center · Updated on 2026-06-02
600
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying how the COVID-19 pandemic has affected the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. This group has worse long-term survival compared to the general population, and the pandemic's impact may be even greater for them. The study aims to understand COVID-19 specific psychological distress in AYA cancer survivors to help develop targeted ways to improve their health and quality of life. Participants complete an online survey lasting 20 to 30 minutes at the start of the study. The survey covers COVID-19 related psychological distress, health care use, health behaviors, social and financial disruptions, health-related quality of life, social support, stress management, and perceived positive effects during stressful times. Participants may be contacted again at 6 months and 1 year to repeat the survey and track changes. During the study, participants provide self-reported information through surveys at baseline, 6 months, and 12 months. Researchers measure COVID-19 specific psychological stress and related factors over time. The study collects patient-reported outcomes and tracks changes in survey responses to understand how the pandemic has influenced their well-being. This ongoing monitoring helps assess the impact of COVID-19 on AYA cancer survivors.
CONDITIONS
Brief Title
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Initial cancer diagnosis between the ages of 15 to 39
- Received any cancer treatment at MD Anderson Cancer Center with data available in the tumor registry
- Confirmed alive at time of contact
- Able to complete questionnaires in English
You will not qualify if you...
- Inability to complete questionnaires in English
- Seen at MD Anderson for a second opinion or non-treatment related visit
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (online)
Duration - 20 to 30 minutes
Participants complete an initial online survey about COVID-19 specific psychological distress, health care utilization, health behavior, social and financial disruptions, health-related quality of life, social support, perceived benefits under times of stress, and the ability to manage stress.
1 baseline survey session (online)
Duration - 12 months
Participants may be contacted again at 6 months and 1 year to complete follow-up surveys evaluating changes in COVID-19 specific psychological distress and related outcomes.
2 follow-up survey sessions (online) at 6 months and 12 months
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
M
Michael E Roth, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here